comparemela.com
Home
Live Updates
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy : comparemela.com
Everest Medicines Announces New Drug Application Acceptance by Singapore HSA for Nefecon for the Treatment of Primary IgA Nephropathy
/PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and...
Related Keywords
South Korea
,
Hong Kong
,
China
,
Shanghai
,
Taiwan
,
Macau
,
Singapore
,
Chinese
,
Korea
,
Rogers Yongqing Luo
,
Drug Administration
,
Korea Ministry Of Food
,
Singapore Health Sciences Authority
,
Priority Review
,
New Drug Application
,
Mainland China
,
Chief Executive Officer
,
Breakthrough Therapy Designation
,
Drug Safety
,
Global Innovative
,
Fast Track
,
Taiwan Food
,
Accelerated Approval Designation
,
Everest Medicines
,
Everest Medicine
,
comparemela.com © 2020. All Rights Reserved.